During the active phase of the experiment (conducted for 2 months), patients from group A received tamsulosin 0.4 mg/day once and solifenacin at a double dose of 20 mg/day once, patients from group B received tamsulosin 0.4 mg/day and solifenacin in a standard dose of 10 mg/day once, patients from group C received a placebo.
The text above was approved for publishing by the original author.
Simplemente dirígete a tu casilla, presiona en el enlace de confirmación que te hemos enviado y recibirás el texto corregido. Si quieres corregir más correos electrónicos, puedes simplemente:
Ó